Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Glucose Tolerance Test × Other × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Other 1 Lymphoid 1

Conditions

Polycystic Ovary Syndrome 1 Obesity 1 Fatty Liver 1

Interventions

Surveys and Questionnaires 9 Blood Specimen Collection 5 naloxegol 3 Therapeutics 3 Observation 3 Interviews as Topic 3 Bariatric Surgery 3 semaglutide 2 naldemedine 2 exemestane 2 Tirzepatide 2 Tamoxifen 2 Psychiatric Rehabilitation 2 Paclitaxel 2 Hematologic Tests 2 Esophagectomy 2 Echocardiography 2 Carboplatin 2 Biopsy 2 BaseLine dental cement 2 Anastrozole 2 trametinib 1 sotorasib 1 selpercatinib 1 pembrolizumab 1 osimertinib 1 lorlatinib 1 dabrafenib 1 cemiplimab 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03041129 2024-04-17

PLUM

University of Colorado, Denver

19 enrolled 10 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡